Echinocandin antifungal drugs
Top Cited Papers
- 1 October 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 362 (9390) , 1142-1151
- https://doi.org/10.1016/s0140-6736(03)14472-8
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive AspergillosisAntimicrobial Agents and Chemotherapy, 2002
- Overexpression of Sbe2p, a Golgi Protein, Results in Resistance to Caspofungin in Saccharomyces cerevisiaeAntimicrobial Agents and Chemotherapy, 2002
- Caspofungin in Combination with Itraconazole for the Treatment of Invasive Aspergillosis in HumansClinical Infectious Diseases, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Correlation between Antifungal Susceptibilities of Coccidioides immitis In Vitro and Antifungal Treatment with Caspofungin in a Mouse ModelAntimicrobial Agents and Chemotherapy, 2001
- Antifungal Drug Resistance in AspergillusJournal of Infection, 2000
- Efficacy of FK463, a (1,3)-β- d -Glucan Synthase Inhibitor, in Disseminated Azole-Resistant Candida albicans Infection in MiceAntimicrobial Agents and Chemotherapy, 2000
- International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agentsDiagnostic Microbiology and Infectious Disease, 1999
- Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiaeJournal of General Microbiology, 1993